Optical Coherence Tomography in Multiple Sclerosis

Clinical Applications
Herausgegeben:Petzold, Axel

• Broschiertes Buch

Produktbeschreibung

This book gives a clinical context to optical coherence tomography (OCT) findings, while considering the differential diagnosis and providing patient management guidance.

Relevant anatomical and technical aspects are discussed, followed by a pragmatic illustration of the use of OCT for the clinical spectrum of multiple sclerosis and optic neuritis, and finishing with information on monitoring ocular side effects of recently approved disease-modifying treatments in multiple sclerosis.

Optical Coherence Tomography in Multiple Sclerosis: Clinical Applications is aimed at clinical neurologists working with patients suffering from MS and general neurologists who see patients with visual symptoms in their daily practice. Ophthalmologists sharing clinical responsibilities with neurologists for patients under disease-modifying treatments will also find the book of interest.

Produktdetails

• Verlag: Springer / Springer International Publishing / Springer, Berlin
• Artikelnr. des Verlages: 978-3-319-35986-1
• Softcover reprint of the original 1st ed. 2016
• Seitenzahl: 212
• Erscheinungstermin: 21. Februar 2018
• Englisch
• Abmessung: 254mm x 178mm x 11mm
• Gewicht: 457g
• ISBN-13: 9783319359861
• ISBN-10: 331935986X
• Artikelnr.: 53574033

Autorenporträt

>190 articles in peer reviewed Journals (77 first author) with a cumulative impact factor >720 and a H-Index of 41.

Inhaltsangabe

Introduction: Clinical Application of OCT in Multiple Sclerosis.- Anatomy of the Retina and the Optic Nerve.- Optical Coherence Tomography (OCT).- MS-associated Optic Neuritis (MSON).- Clinical Use of OCT and MSON Mimics.- OCT Findings in Neuromyelitis Optica Spectrum Disorders.- OCT and Early MS: Clinically Isolated Syndromes.- OCT in Relapsing Remitting Multiple Sclerosis (RRMS).- Progressive Multiple Sclerosis (SP PP MS).- Retrograde Maculopathy.- Monitoring Treatment in Multiple Sclerosis.- Drug Trials in Neuroprotection.- Role of the OCT Reading Center.